Federal contract award

75N90026F00006

PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH - CC
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicle36F79725D0093
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$529.3K
Current contract value$529.3K
Potential contract value / ceiling$529.3K
Start dateOct 1, 2025
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityApr 29, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 29, 2026P00002$180.4KPYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.
Feb 27, 2026P00001$185.6KOPTION PERIOD 1 - PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-003439] [26-000012]
Dec 16, 20250$163.2KPYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Lu ChangContactlu-chang.lu@nih.govSourceSep 25, 2025
Lu ChangContactlu-chang.lu@nih.govSourceSep 25, 2025
Lu ChangContactlu-chang.lu@nih.govSourceSep 25, 2025

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.